» Articles » PMID: 28029718

A SMART Data Analysis Method for Constructing Adaptive Treatment Strategies for Substance Use Disorders

Overview
Journal Addiction
Specialty Psychiatry
Date 2016 Dec 29
PMID 28029718
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To demonstrate how Q-learning, a novel data analysis method, can be used with data from a sequential, multiple assignment, randomized trial (SMART) to construct empirically an adaptive treatment strategy (ATS) that is more tailored than the ATSs already embedded in a SMART.

Method: We use Q-learning with data from the Extending Treatment Effectiveness of Naltrexone (ExTENd) SMART (N = 250) to construct empirically an ATS employing naltrexone, behavioral intervention, and telephone disease management to reduce alcohol consumption over 24 weeks in alcohol dependent individuals.

Results: Q-learning helped to identify a subset of individuals who, despite showing early signs of response to naltrexone, require additional treatment to maintain progress.

Conclusions: Q-learning can inform the development of more cost-effective, adaptive treatment strategies for treating substance use disorders.

Citing Articles

Optimizing Allocation to Telehealth and In-Person Prolonged Exposure for Women Veterans with Military Sexual Trauma: A Precision Medicine Approach.

Argyriou E, Gros D, Hernandez Tejada M, Muzzy W, Acierno R Behav Sci (Basel). 2024; 14(11).

PMID: 39594293 PMC: 11591394. DOI: 10.3390/bs14110993.


Simulating A/B testing versus SMART designs for LLM-driven patient engagement to close preventive care gaps.

Basu S, Schillinger D, Patel S, Rigdon J NPJ Digit Med. 2024; 7(1):322.

PMID: 39558021 PMC: 11574204. DOI: 10.1038/s41746-024-01330-2.


Examining engagement effects in an adaptive preventive intervention for college student drinking.

Patrick M, Sur A, Arterberry B, Peterson S, Morrell N, Vock D J Consult Clin Psychol. 2023; 91(11):652-664.

PMID: 37650825 PMC: 10591876. DOI: 10.1037/ccp0000845.


Recent innovations in adaptive trial designs: A review of design opportunities in translational research.

Kaizer A, Belli H, Ma Z, Nicklawsky A, Roberts S, Wild J J Clin Transl Sci. 2023; 7(1):e125.

PMID: 37313381 PMC: 10260347. DOI: 10.1017/cts.2023.537.


Design of experiments with sequential randomizations on multiple timescales: the hybrid experimental design.

Nahum-Shani I, Dziak J, Venera H, Pfammatter A, Spring B, Dempsey W Behav Res Methods. 2023; 56(3):1770-1792.

PMID: 37156958 PMC: 10961682. DOI: 10.3758/s13428-023-02119-z.


References
1.
Lei H, Nahum-Shani I, Lynch K, Oslin D, Murphy S . A "SMART" design for building individualized treatment sequences. Annu Rev Clin Psychol. 2012; 8:21-48. PMC: 3887122. DOI: 10.1146/annurev-clinpsy-032511-143152. View

2.
Laber E, Zhao Y, Regh T, Davidian M, Tsiatis A, Stanford J . Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy. Stat Med. 2015; 35(8):1245-56. PMC: 4777666. DOI: 10.1002/sim.6783. View

3.
Zhao Y, Zeng D, Laber E, Song R, Yuan M, Kosorok M . Doubly Robust Learning for Estimating Individualized Treatment with Censored Data. Biometrika. 2015; 102(1):151-168. PMC: 4414056. DOI: 10.1093/biomet/asu050. View

4.
Murphy S . An experimental design for the development of adaptive treatment strategies. Stat Med. 2004; 24(10):1455-81. DOI: 10.1002/sim.2022. View

5.
Heilig M, Egli M . Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther. 2006; 111(3):855-76. DOI: 10.1016/j.pharmthera.2006.02.001. View